Barclays PLC Form 8.5 (EPT/NON-RI)-CLINIGEN GROUP PLC (0695G)
March 25 2022 - 6:55AM
UK Regulatory
TIDMBARC TIDMCLIN
RNS Number : 0695G
Barclays PLC
25 March 2022
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS
(OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: BARCLAYS CAPITAL SECURITIES LTD
--------------------------------------
(b) Name of offeror/offeree in relation to whose CLINIGEN GROUP PLC
----------------------------------------------
relevant securities this form
relates:
-------------- -------------------------------------- ------------ --------------------- ---------------------
(c) Name of the party to the offer with which exempt Triley Bidco Limited (a newly-formed company
indirectly owned by Triton Funds)
----------------------------------------------
principal trader is connected
-------------- -------------------------------------- ------------ --------------------- ---------------------
(d) Date position held/dealing 24 March 2022
undertaken:
-------------- -------------------------------------- ------------ ----------------------------------------------
(e) In addition to the company in 1(b) above, is the NO
exempt principal
trader making disclosures in respect of any other
party to the offer?
-------------- ---------------------------------------------------- --------------------- ---------------------
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
(a) Interests and short positions in the relevant securities of the offeror or offeree
to which the disclosure relates following the dealing (if any)
Class of relevant security: 0.1p ordinary
--------------------------- --------------------------------------------
Interests Short Positions
--------------------------- --------------------------------------------
Number (%) Number (%)
--------------------------------------- ------------- ------------ --------------------- ---------------------
(1) Relevant securities
owned
and/or controlled: 1,782,290 1.34% 567,963 0.43%
(2) Cash-settled
derivatives:
543,572 0.41% 1,374,729 1.03%
(3) Stock-settled
derivatives (including
options)
and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL: 2,325,862 1.74% 1,942,692 1.46%
(b) Rights to subscribe for new securities (including directors and other executive
options)
Class of relevant security in relation to
-----------
which subscription right exists
-------------------------------------------- ------------ ----------------------------------------------------------
Details, including nature of the rights
-----------
concerned and relevant percentages:
-------------------------------------------- ------------ ----------------------------------------------------------
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
------------ ------------------------------ ------------ ----------- ------ --------------------- --------------
Class of Purchase/sale Total Highest price per Lowest price
relevant number of unit per unit
security securities paid/received paid/received
------------ ------------- --------------- ------------ ----------- ------ --------------------- --------------
0.1p ordinary Purchase 44,103 9.2200 GBP 9.205 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary Sale 31,606 9.2100 GBP 9.2024 GBP
----------------------------- ------------------- --------------------- --------------
(b) Cash-settled derivative transactions
------------ -------------------------------------------- ----------- ------ --------------------- --------------
Class of Product Nature of Number of Price per
dealing
relevant description reference unit
security securities
------------ ------------- --------------- ------------ ----------- ------ --------------------- --------------
0.1p ordinary SWAP Decreasing Short 126 9.2042 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 413 9.2100 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 659 9.2196 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 1,741 9.2114 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 2,195 9.2108 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 6,007 9.2016 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 8,860 9.2214 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 10,691 9.2100 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary SWAP Decreasing Short 23,769 9.2037 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary CFD Increasing Short 2,280 9.2199 GBP
----------------------------- ------------------- --------------------- --------------
0.1p ordinary CFD Increasing Short 17,100 9.2118 GBP
----------------------------- ------------------- --------------------- --------------
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
------------- --------------- ------------ ----------- ------ --------------------- --------------
(ii) Exercising
Class of relevant Product description Exercising/ Number of Exercise
exercised against price per
security securities unit
------------ ------------- --------------- ------------ --------------------- --------------
(d) Other dealings (including subscribing for new
securities)
Class of Nature of Details Price per unit (if
relevant Dealings
security applicable)
------------ ------------- --------------- ------------ --------------------- --------------
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure
and any party
to the offer or any person acting in concert with a party to the
offer:
----------------------------------------------------------------------- ------ --------------------- --------------
NONE
----------------------------------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the exempt principal trader making the disclosure and any other person
relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
-------------------------------------------- ------------ ----------- ------ --------------------- --------------
NONE
----------------------------------------------------------------------------------------------------------------------
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
----------------------------------------------------------
Date of disclosure: 25 Mar
2022
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
------------------- --------------------- --------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FEOBKPBPKBKDNNB
(END) Dow Jones Newswires
March 25, 2022 06:55 ET (10:55 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2024 to Aug 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Aug 2023 to Aug 2024
